SAB Biotherapeutics Inc Earnings

The next earnings date for SAB Biotherapeutics Inc has not yet been scheduled.

Analyst Estimates of SAB Biotherapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

SAB Biotherapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/19/2025After Market$-0.5647.79%
03/26/2025After Market------
11/12/2024Before Market$-1.12-2.75%
08/08/2024After Market$-0.7930.09%
05/20/2024After Market$-0.5443.75%
03/29/2024Before Market$-3.38-445.16%
11/13/2023After Market$-0.1016.67%
08/21/2023Before Market$-0.140.00%
05/15/2023After Market$-0.15-87.50%
03/31/2023After Market$-0.160.00%
11/15/2022Before Market$-0.160.00%
08/10/2022Before Market$-0.1135.29%
05/12/2022After Market$0.02112.50%
03/29/2022After Market$-0.66-500.00%
11/22/2021After Market$-0.0277.78%
08/09/2021After Market$-0.03---
05/21/2021After Market$0.84---

More About SAB Biotherapeutics Inc

Website
https://www.sabbiotherapeutics.com
Country
USA
Full Time Employees
63

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

“SAB Biotherapeutics Inc Earnings” Can Refer to the SAB Biotherapeutics Inc Earnings Date

Some people say “SAB Biotherapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my SAB Biotherapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning SAB Biotherapeutics Inc Stock on the Earnings Date

If you own SAB Biotherapeutics Inc stock (SABS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for SAB Biotherapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading SAB Biotherapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More SAB Biotherapeutics Inc Earnings

You can contact us any time if you would like to ask questions about SAB Biotherapeutics Inc earnings or anything else related to the stock market.